This inventor holds 7 USPTO granted patents and 5 published patent applications and 8 EPO patents. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2017-2020.
Company Filing History:
Years Active: 2017-2020
Title: Zhiqi Qi: Innovator in Pharmaceutical Chemistry
Introduction
Zhiqi Qi is a prominent inventor based in Shanghai, China, known for his significant contributions to pharmaceutical chemistry. With a total of seven patents to his name, Qi has made remarkable advancements in the field, particularly in drug development and pharmacokinetics.
Latest Patents
Among his latest patents, Qi has developed piperidine or piperazine linked imidazole and triazole derivatives. This invention relates to compounds that improve the pharmacokinetics of drugs, particularly those metabolized by CYP3A4. These compounds are valuable in both human and veterinary medicine. Another notable patent is focused on TrkA kinase inhibitors, which are bicyclic heteroaryl benzamide compounds. These inhibitors are useful in treating various conditions, including pain, inflammation, and cancer.
Career Highlights
Zhiqi Qi has worked with notable companies such as Merck Sharp & Dohme Corporation and MSD R&D Co., Ltd. His work in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout his career, Qi has collaborated with esteemed colleagues, including Chun Sing Li and Craig Alan Coburn. These partnerships have fostered innovation and have been instrumental in advancing his research.
Conclusion
Zhiqi Qi's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to impact drug development and improve therapeutic outcomes.